Back to Search
Start Over
Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy.
- Source :
- Molecular Pharmaceutics; 7/4/2022, Vol. 19 Issue 4, p2105-2114, 10p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15438384
- Volume :
- 19
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Molecular Pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 157835475
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.1c00994